Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02096263 |
|---|---|
| Brief Title: | Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants |
| First Submitted : | March 21, 2014 |
| First Submitted that Met QC Criteria : | March 21, 2014 |
| First Posted : | March 26, 2014 (Estimate) |
| Results First Submitted : | July 5, 2018 |
| Results First Submitted that Met QC Criteria : | July 5, 2018 |
| Results First Posted : | August 1, 2018 |
| Certification/Extension First Submitted : | August 30, 2017 |
| Certification/Extension First Submitted that Met QC Criteria : | August 30, 2017 |
| Certification/Extension First Posted : | September 1, 2017 |
| Last Update Submitted that Met QC Criteria : | August 9, 2018 |
| Last Update Posted : | September 7, 2018 |